abstract |
In the PLCβ4 gene-deficient mouse of the present invention, SWD, which is characteristic of Apex epilepsy, is observed, and SWD decreases when a therapeutic agent for Apex epilepsy is administered, and thus, the PLCβ4 gene-deficient mouse is useful as an animal model for verifying the effect of Apex epilepsy treatment. Can be used. |